Detalles de la búsqueda
1.
A heterologous prime-boost strategy for immunization against Dengue virus combining the Tetra DIIIC subunit vaccine candidate with the TV005 live-attenuated tetravalent vaccine.
J Gen Virol
; 100(6): 975-984, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31090533
2.
A Tetravalent Formulation Based on Recombinant Nucleocapsid-like Particles from Dengue Viruses Induces a Functional Immune Response in Mice and Monkeys.
J Immunol
; 197(9): 3597-3606, 2016 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27683751
3.
A dose-response study in mice of a tetravalent vaccine candidate composed of domain III-capsid proteins from dengue viruses.
Arch Virol
; 162(8): 2247-2256, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28393307
4.
Generation and characterization of potential dengue vaccine candidates based on domain III of the envelope protein and the capsid protein of the four serotypes of dengue virus.
Arch Virol
; 159(7): 1629-40, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24420159
5.
Recombinant protein based on domain III and capsid regions of zika virus induces humoral and cellular immune response in immunocompetent BALB/c mice.
Vaccine
; 41(40): 5892-5900, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37599141
6.
The tetravalent formulation of domain III-capsid proteins recalls memory B- and T-cell responses induced in monkeys by an experimental dengue virus infection.
Clin Transl Immunology
; 6(6): e148, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28748091
Resultados
1 -
6
de 6
1
Próxima >
>>